Psychosocial Intervention for Brain Cancer
Trial Summary
What is the purpose of this trial?
The goal of this study is to test a psychosocial intervention called ASCENT (ACT-based Supportive intervention for patients with CENTral nervous system tumors). This intervention was developed to help patients after being diagnosed with a brain tumor. The main question this study aims to answer is whether this intervention is feasible (i.e., possible to carry out) and acceptable (i.e., considered helpful) to patients. Participants will be asked to take part in 6 coaching sessions and complete short surveys at four different time points. Some participants will be asked to share feedback via interviews.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment ASCENT for brain cancer?
Research shows that behavioral pain interventions, like those used in ASCENT, can reduce pain and improve outcomes for cancer patients, especially in underserved areas. These interventions have been effective in reducing pain severity and improving physical and psychological well-being in similar contexts.12345
Is the psychosocial intervention for brain cancer safe for humans?
How is the psychosocial intervention for brain cancer different from other treatments?
This psychosocial intervention is unique because it focuses on improving the management of cancer-related symptoms like pain, depression, and fatigue through tailored education and behavioral strategies, rather than using medication. It may involve mobile-health technologies to reach underserved patients, making it accessible and feasible for those who might not have easy access to traditional healthcare services.126711
Research Team
Deborah Forst, MD
Principal Investigator
Massachusetts General Hospital
Eligibility Criteria
This trial is for adults over 18 who were diagnosed with a malignant brain tumor within the last 6 months, are patients at Massachusetts General Hospital Cancer Center, and speak English. It's not for those unable to consent (due to severe cognitive issues), in or near hospice care, or with significant difficulty understanding language.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the ASCENT intervention, consisting of six weekly or biweekly individual sessions with a clinician
Follow-up
Participants are monitored for psychological and behavioral outcomes, including depression, loneliness, anxiety, coping skills, prognostic distress, and quality of life
Treatment Details
Interventions
- ASCENT
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor